National Planning Corporation’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-8,935
| Closed | -$453K | – | 255 |
|
|
2017
Q3 | $453K | Sell |
8,935
-1,114
| -11% | -$56.5K | 0.04% | 389 |
|
|
2017
Q2 | $537K | Buy |
10,049
+1,611
| +19% | +$86.1K | 0.04% | 388 |
|
|
2017
Q1 | $443K | Sell |
8,438
-631
| -7% | -$33.1K | 0.03% | 411 |
|
|
2016
Q4 | $446K | Buy |
9,069
+465
| +5% | +$22.9K | 0.03% | 402 |
|
|
2016
Q3 | $418K | Buy |
8,604
+330
| +4% | +$16K | 0.03% | 398 |
|
|
2016
Q2 | $470K | Buy |
8,274
+1,309
| +19% | +$74.4K | 0.04% | 390 |
|
|
2016
Q1 | $367K | Sell |
6,965
-3,782
| -35% | -$199K | 0.03% | 431 |
|
|
2015
Q4 | $548K | Buy |
10,747
+5,094
| +90% | +$260K | 0.04% | 382 |
|
|
2015
Q3 | $301K | Sell |
5,653
-10,738
| -66% | -$572K | 0.03% | 461 |
|
|
2015
Q2 | $917K | Sell |
16,391
-1,735
| -10% | -$97.1K | 0.08% | 233 |
|
|
2015
Q1 | $1.03M | Sell |
18,126
-25
| -0.1% | -$1.43K | 0.09% | 207 |
|
|
2014
Q4 | $955K | Buy |
18,151
+5,443
| +43% | +$287K | 0.07% | 255 |
|
|
2014
Q3 | $727K | Sell |
12,708
-9,604
| -43% | -$549K | 0.06% | 316 |
|
|
2014
Q2 | $1.49M | Buy |
22,312
+143
| +0.6% | +$9.56K | 0.12% | 181 |
|
|
2014
Q1 | $1.47M | Buy |
22,169
+1,958
| +10% | +$130K | 0.13% | 168 |
|
|
2013
Q4 | $1.34M | Buy |
20,211
+5,992
| +42% | +$398K | 0.12% | 188 |
|
|
2013
Q3 | $898K | Buy |
14,219
+2,938
| +26% | +$186K | 0.09% | 236 |
|
|
2013
Q2 | $698K | Buy |
+11,281
| New | +$698K | 0.09% | 234 |
|